In NSCLC patients, Fut8 could be regarded as an unfavorable prognostic factor of potentially curatively resection, but it can be a potential therapeutic target for NSCLC (46) (Table 1). The gene discussed is FUT8; the disease is non-small cell lung carcinoma.